Intratracheal Administration of Hepatocyte Growth Factor/Scatter Factor Stimulates Rat Alveolar Type II Cell Proliferation in Vivo

American Journal of Respiratory Cell and Molecular Biology

Volumn 15, Issue 5, 1996, Pages 574-581

  Panos, Ralph J ^a   Patel, Rakesh ^a   Bak, Philip M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; ARMORACIA RUSTICANA;

ANTIGEN; BROXURIDINE; DNA; LECTIN; MACLURIN; PLANT LECTIN; SCATTER FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG INSTILLATION; ENZYME IMMUNOASSAY; HYPEROXIA; LUNG ALVEOLUS; MALE; RAT; SPRAGUE DAWLEY RAT; TRACHEA;

ANIMALS; ANTIGENS; BROMODEOXYURIDINE; CELL DIVISION; DNA; HEPATOCYTE GROWTH FACTOR; HYPEROXIA; IMMUNOENZYME TECHNIQUES; INSTILLATION, DRUG; LECTINS; MALE; PLANT LECTINS; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; TRACHEA;

EID: 0030293210     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.15.5.8918364     Document Type: Article

References (54)

1. Witschi, H. P. 1976. Proliferation of type II alveolar cells: a review of common responses in toxic lung injury. Toxicology 5:267-277.
2. Haschek, W. M., and Witschi, H. 1979. Pulmonary fibrosis - a possible mechanism. Toxicol. Appl. Pharm. 51:475-487.
3. Balis, J. U., J. F. Patterson, E. M. Haller, S. A. Shelley, and M. R. Montgomery. 1988. Ozone-induced lamellar body responses in a rat model for alveolar injury and repair. Am. J. Pathol. 132:330-344.
4. Adamson, I. Y. R., and D. H. Bowden. 1984. Role of polymorphonuclear leukocytes in silica-induced pulmonary fibrosis. Am. J. Pathol. 117: 37-43.
5. Brody, A. R., and L. H. Overby. 1989. Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestos exposed rats. Am. J. Pathol. 134:133-140.
6. Adamson, I. Y. R., and D. H. Bowden. 1974. The type 2 cell as progenitor of alveolar epithelial regeneration a cytodynamic study in mice after exposure to oxygen. Lab. Invest. 30:35-42.
7. Adamson, I. Y. R., D. H. Bowden, and J. P. Wyatt. 1970. Oxygen poisoning in mice. Ultrastructural and surfactant studies during exposure and recovery. Arch. Pathol 90:463-472.
8. Bowden, D. H., and I. Y. R. Adamson. 1971. Reparative changes following pulmonary cell injury. Ultrastructural, cytodynamic, and surfactant studies in mice after oxygen exposure. Arch. Pathol. 92:279-283.
9. Evans, M. J., L. V. Johnson, R. J. Stephens, and G. Freeman. 1976. Cell renewal in the lungs of rats exposed to low levels of ozone. Exp. Mol. Pathol. 24:70-83.
10. 3. Lab. Invest. 35:246-257.
11. Eustis, S. L., L. W. Schwartz, P. C. Kosch, and D. L. Dungworth. 1981. Chronic bronchiolitis in nonhuman primates after prolonged ozone exposure. Am. J. Pathol. 105:121-137.
12. Crapo, J. D., M. Peters-Golden, J. Marsh-Salin, and J. S. Shelburne. 1978. Pathologic changes in the lungs of oxygen-adapted rats. A morphometric analysis. Lab. Invest. 39:640-653.
13. Crapo, J. D., B. E. Barry, H. A. Foscue, and J. Shelburne. 1980. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 122:123-143.
14. Thet, L. A., S. C. Parra, and J. D. Shelburne. 1986. Sequential changes in lung morphology during the repair of acute oxygen-induced lung injury in adult rats. Exp. Lung Res. 11:209-228.
15. Evans, M. J., N. P. Dekker, L. J. Cabral-Anderson, and G. Freeman. 1978. Quantitation of damage to the alveolar epithelium by means of type 2 cell proliferation. Am. Rev. Respir. Dis. 118:787-790.
16. Panos, R. J. 1992. Cytokines and alveolar type II cells. In Cytokines and the Lung. J. Kelley, editor. New York, Marcel Dekker. 417-456.
17. Sundell, H. W., M. E. Gray, R. S. Serenius, M. B. Escobedo, and M. T. Stahtman. 1980. Effect of epidermal growth factor on lung maturation in fetal lambs. Am. J. Pathol. 100:707-726.
18. Catterton, W. Z., M. B. Escobedo, W. R. Sexson, M. E. Gray, H.W. Sundell, and M. T. Stahlman. 1979. Effect of epidermal growth factor on lung maturation in fetal rabbits. Pediat. Res. 13:104-108.
19. Ulich, T. R., E. S. Yi, K. Longmuir, S. Yin, R. Bilitz, C. F. Morris, R. M. Housley, and G. F. Pierce. 1994. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest. 93: 1298-1306.
20. Panos, R. J., P. M. Bak, W. S. Simonet, J. S. Rubin, and L. J. Smith. 1995. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J. Clin. Invest. 96:2026-2033.
21. Panos, R. J., J. S. Rubin, S. A. Aaronson, and R. J. Mason. 1993. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast conditioned medium. J. Clin. Invest. 92:969-977.
22. Zioncheck, T. F., L. Richardson, J. Liu, L. Chang, K. L. King, G. L. Bennett, P. Fugedi, S. M. Chamow, R. H. Schwall, and R. J. Stack. 1995. Sulfated oligosaccharides promote hepatocyte growth association and govern its mitogenic activity. J. Biol. Chem. 270:16871-16878.
23. Smith, L. F., M. Shamsuddin, J. Anderson, and W. Hsueh. 1988. Hyperoxic lung damage in mice: appearance and bioconversion of peptide leukotrienes. J. Appl. Physiol. 64:944-951.
24. Smith, L. J., E. Sommers, C. E. Hunt, and L. Pachman. 1986. Hyperoxic lung injury in mice: a possible protective role for prostacyclin. J. Lab. Clin. Med. 108:479-488.
25. Smith, L. J., H. Friedman, and J. Anderson. 1988. Hyperoxic lung injury in mice: effect of neutrophil depletion and food deprivation. J. Lab. Clin. Med. 111:449-458.
26. Smith, L. J. 1985. Hyperoxic lung injury: biochemical, cellular, and morphological characterization in the mouse. J. Lab. Clin. Med. 106:269-278.
27. Miller, Y. E., S. R. Walker, J. S. Spencer, R. T. Kubo, and R. J. Mason. 1989. Monoclonal antibodies specific for antigens expressed by rat type II alveolar epithelial and nonciliated bronchiolar cells. 15:635-649.
28. Merchenthaler, I., J. Stankovics, and F. Gallyas. 1989. A highly sensitive one-step method for silver intensification of the nickel-diaminobenzidine end-product of peroxidase reaction. J. Histochem. Cytochem. 37:1563-1565.
29. Weller, N. K., and M. J. Karnovsky. 1989. Identification of a 185 kd Maclura pomifera agglutinin binding glycoprotein as a candidate for differentiation marker for alveolar type II cells in adult rat lung. Am. J. Pathol. 134:277-285.
30. Dobbs, L. G. 1990. Isolation and culture of alveolar type II cells. Am. J. Physiol. 258(Lung Cell. Mol. Physiol. 2):L134-L147.
31. Hayashi, Y., M. Koike, M. Matsutani, and T. Hoshino. 1988. Effects of fixation time and enzymatic digestion on immunohistochemical demonstration of bromodeoxyuridine in formalin-fixed, paraffin-embedded tissue. J. Histochem. Cytochem. 36:511-514.
32. Sugihara, H., T. Hattori, and M. Fukuda. 1986. Immunohistochemical detection of bromodeoxyuridine in formalin-fixed tissues. Histochemistry 85:193-195.
33. Schutte, B., M. M. J. Reynders, F. T. Bosman, and G. H. Blijham. 1987. Effect of tissue fixation on anti-bromodeoxyuridine immunohistochemistry. J. Histochem. Cytochem. 35:1343-1345.
34. Soriano, E., and J. A. Del Rio. 1991. Simultaneous immunocytochemical visualization of bromodeoxyuridine and neural tissue antigens. J. Histochem. Cytochem. 39:255-263.
35. Nakane, P. K. 1968. Simultaneous localization of multiple tissue antigens using the peroxidase-labeled antibody method: a study on pituitary glands of the rat. J. Histochem. Cytochem. 16:557-558.
36. 2 oxidation strikingly improves silver intensification of the nickel-diaminobenzidine (Ni-DAB) end-product of the peroxidase reaction. J. Histochem. Cytochem. 36:807-810.
37. Vigna, E., L. Naldini, L. Tamagnone, P. Langati, A. Bardelli, F. Maina, C. Ponzetto, and P. M. Comoglio. 1994. Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-met proto-oncogene. Cell Mol. Biol. 40:597-604.
38. Mason, R. J., C. C. Leslie, K. McCormick-Shannon, R. R. Deterding, T. Nakamura, J. S. Rubin, and J. M. Shannon. 1994. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 11:561-567.
39. Shiratori, M., G. Michalopoulos, H. Shinozuka, G. Singh, H. Ogasawara, and S. L. Katyal. 1995. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro. Am. J. Respir. Cell Mol. Biol. 12:171-180.
40. Ishiki, Y., H. Ohnishi, Y. Muto, K. Matsumoto, and T. Nakamura. 1992. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16:1227-1235.
41. Fujiwara, K., S. Nagoshi, A. Ohno, K. Hirata, Y. Ohta, S. Mochida, T. Tomiya, K. Higashio, and K. Kurokawa. 1993. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 18:1443-1449.
42. Zioncheck, T. F., L. Richardson, G. G. DeGuzman, N. B. Modi, S. E. Hansen, and P. J. Godowski. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology 134:1879-1887.
43. Appasamy, R., M. Tanabe, N. Murase, R. Zarnegar, R. Venkataramanan, D. H. Van Thiel, and G. K. Michalopoulos. 1993. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab. Invest. 68:270-276.
44. Roos, R., T. G. Terrell, P. J. Godowski, S. M. Chamow, and R. H. Schwall. 1992. Reduction of alpha-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor. Endocrinology 131:2540-2544.
45. Roos, F., A. M. Ryan, S. M. Chamow, G. L. Bennett, and R. H. Schwall. 1995. Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor. Am. J. Physiol. 268(Gastrointest. Liver Physiol. 31):G380-G386.
46. Raza, A., H. D. Preisler, G. L. Mayers, and R. Bankert. 1984. Rapid enumeration of S-phase cells by means of monoclonal antibodies. N. Engl. J. Med. 310:991.
47. Van Furth, R., and T. L. Van Zwet. 1988. Immunocytochemical detection of 5-bromodeoxyuridine incorporation in individual cells. J. Immunol. Methods 108:45-51.
48. Lin, P., and D. C. Allison. 1993. Measurement of DNA content and of tritiated thymidine and bromodeoxyuridine incorporation by the same cells. J. Histochem. Cytochem. 41:1435-1439.
49. Walker, S. R., M. C. Williams, and B. Benson. 1986. Immunocytochemical localization of the major surfactant apoproteins in type II cells, Clara cells and alveolar macrophages of rat lung. J. Histochem. Cytochem. 34:1137-1148.
50. Williams, M. C., and B. J. Benson. 1981. Immunocytochemical localization and identification of the major surfactant protein in adult rat lung. J. Histochem. Cytochem. 29:291-305.
51. Williams, M. C., S. Hawgood, D. B. Schenck, J. Lewicki, and M. N. Phelps. 1988. Monoclonal antibodies to surfactant proteins of SP28-36 label canine type II and nonciliated bronchiolar cells by immunofluorescence. Am. Rev. Respir. Dis. 137:399-405.
52. Kogishi, K., M. Kurozumi, Y. Fujita, T. Murayama, F. Kuze, and Y. Suzuki. 1988. Isolation and partial characterization of human low molecular weight protein associated with pulmonary surfactant. Am. Rev. Respir. Dis. 137:1426-1431.
53. Weaver, T. E., V. K. Sarin, N. Sawtell, W. M. Hull, and J. A. Whitsett. 1988. Identification of surfactant proteolipid SP-B in human surfactant and fetal lung. J. Appl. Physiol. 65:982-987.
54. Funkhouser, J. D., L. B. Cheshire, T. B. Ferrara, and R. D. Peterson. 1987. Monoclonal antibody identification of a type II alveolar epithelial cell antigen and expression of the antigen during lung development. Dev. Biol. 119:190-198.